ResearcherTokyo University of ScienceActive in the last 2 years
Izumi Matsuoka
Known by name at one institution; no external author ID yet. Name as it appears in OpenAlex.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 1, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2023: 1 paper · 2024: 1 paper
Papers 2
- Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells. First author DOI 10.3892/ol.2024.14558↗
- High expression of PKCλ and ALDH1A3 indicates a poor prognosis, and PKCλ is required for the asymmetric cell division of ALDH1A3-positive cancer stem cells in … Co-author DOI 10.1016/j.bbrc.2023.05.086↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Takahiro Kasai · 2 shared papers, 2023–2024
- Paper Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALD… DOI 10.3892/ol.2024.14558↗
- Paper High expression of PKCλ and ALDH1A3 indicates a poor prognosis, and PKCλ is required for the asymmetric cell division o… DOI 10.1016/j.bbrc.2023.05.086↗
- Kazunori Akimoto · 2 shared papers, 2023–2024
- Paper Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALD… DOI 10.3892/ol.2024.14558↗
- Paper High expression of PKCλ and ALDH1A3 indicates a poor prognosis, and PKCλ is required for the asymmetric cell division o… DOI 10.1016/j.bbrc.2023.05.086↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.